ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹3,959 Cr | ₹3,995 Cr | ₹3,707 Cr | ₹4,805 Cr | ₹3,604 Cr |
What is the latest Total Current Liabilities ratio of ALKEM LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹3,959 Cr |
| Mar2024 | ₹3,995 Cr |
| Mar2023 | ₹3,707 Cr |
| Mar2022 | ₹4,805 Cr |
| Mar2021 | ₹3,604 Cr |
How is Total Current Liabilities of ALKEM LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,959 Cr | -0.90 | |
| Mar2024 | ₹3,995 Cr | 7.75 | |
| Mar2023 | ₹3,707 Cr | -22.85 | |
| Mar2022 | ₹4,805 Cr | 33.33 | |
| Mar2021 | ₹3,604 Cr | - | |
Compare Total Current Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹61,541.4 Cr | -3.5% | -4.3% | 9.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,407.0 Cr | -2.2% | 2.5% | 1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,596.0 Cr | -1.2% | -4.5% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,619.0 Cr | -2.1% | -0.2% | 36.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | -2.4% | -2.1% | 11.5% | Stock Analytics | |
| CIPLA | ₹98,767.6 Cr | -4.6% | -8% | -16.8% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -3.5% |
-4.3% |
9.2% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses